PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2024-01-31

Date Title Company
31-Jan-2024 Stemtech Corporation Expands Global Reach with New License Agreement in Africa AccessWire
31-Jan-2024 Eckert & Ziegler to Supply Nucleus Radiopharma with Therapeutic Radioisotopes Ac-225 and Lu-177 Eckert & Ziegler Strahlen- und Medizintechnik AG
31-Jan-2024 Study Unlocks New Hope in the Battle Against Male Infertility AccessWire
31-Jan-2024 Applied DNA Announces $3.44 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules AccessWire
31-Jan-2024 Ensysce Biosciences Announces Positive End of Phase 2 Meeting with FDA for PF614 to Treat Severe Pain AccessWire
31-Jan-2024 Renalogic Partners With AmeriHealth Administrators to Address High-Cost Dialysis Claims for the Marketplace AccessWire
31-Jan-2024 Open Letter to Zomedica Shareholders from your Chief Executive Officer AccessWire
31-Jan-2024 MetrioPharm Publishes First Trial Data Showing Effects of Host-Directed Therapy in COVID-19 MetrioPharm
31-Jan-2024 AlzeCure CEO Martin Jönsson to Present at the International Investor Conference BioCapitalEurope AccessWire
31-Jan-2024 Larodan Partners With Bioz to Provide Researchers With Scientific Product Validation Newswire
31-Jan-2024 Larodan Partners With Bioz to Provide Researchers With Scientific Product Validation AccessWire
31-Jan-2024 New investigator-initiated clinical trials of BellaSeno´s resorbable tissue regeneration scaffolds to be conducted in Europe BellaSeno GmbH
31-Jan-2024 IRLAB: Invitation to the Year-end Report 2023 Presentation and Webcast AccessWire
31-Jan-2024 Kuros Biosciences Receives US FDA 510K Clearance for MagnetOs Granules for Interbody Use and Regulatory Clearance of MagnetOs Granules and MagnetOs Putty in New Zealand AccessWire
31-Jan-2024 Kuros Biosciences Receives US FDA 510K Clearance for MagnetOs Granules for Interbody Use and Regulatory Clearance of MagnetOs Granules and MagnetOs Putty in New Zealand Kuros Biosciences AG